Zobrazeno 1 - 10 of 706 pro vyhledávání: '"Andreu EJ"'
1
Akademický článek
A Bioreactor for Celullarised Membrane Culture and Delivery under Sterile Conditions.
Autor: Gereka A; Health Specialization, Leartiker S. Coop., 48270 Markina-Xemein, Spain., Urtaza U; Health Specialization, Leartiker S. Coop., 48270 Markina-Xemein, Spain., Larreategi P; Health Specialization, Leartiker S. Coop., 48270 Markina-Xemein, Spain., Prosper F; Cell Therapy Area, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Andreu EJ; Cell Therapy Area, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Zaldua AM; Health Specialization, Leartiker S. Coop., 48270 Markina-Xemein, Spain.
Publikováno v: Bioengineering (Basel, Switzerland) [Bioengineering (Basel)] 2024 Aug 02; Vol. 11 (8). Date of Electronic Publication: 2024 Aug 02.
Zobrazit plný text záznamu
2
Akademický článek
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.
Autor: Fernández-Santos ME; Cardiology Department, HGU Gregorio Marañón. GMP-ATMPs Production Unit, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). Complutense University, CIBER Cardiovascular (CIBERCV), ISCIII, Madrid, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., Garcia-Arranz M; New Therapies Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital (IIS-FJD). Surgery Department, Autonoma University of Madrid, Madrid, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., Andreu EJ; Hematology Department and Cell Therapy Area, Clínica Universidad de Navarra. CIBEROC and IDISNA, Pamplona, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., García-Hernández AM; Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., López-Parra M; Cell Therapy Area and Hematology Department, IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., Villarón E; Cell Therapy Area and Hematology Department, IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., Sepúlveda P; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., Fernández-Avilés F; Cardiology Department, HGU Gregorio Marañón. GMP-ATMPs Production Unit, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). Complutense University, CIBER Cardiovascular (CIBERCV), ISCIII, Madrid, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., García-Olmo D; New Therapies Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital (IIS-FJD). Surgery Department, Autonoma University of Madrid, Madrid, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., Prosper F; Hematology Department and Cell Therapy Area, Clínica Universidad de Navarra. CIBEROC and IDISNA, Pamplona, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., Sánchez-Guijo F; Cell Therapy Area and Hematology Department, IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., Moraleda JM; Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain., Zapata AG; Department of Cell Biology, Complutense University, Madrid, Spain.; Platform GMP Units from TerCel and TERAV Networks. RETIC TerCel & RICORS TERAV, ISCIII, Madrid, Spain.
Publikováno v: Frontiers in immunology [Front Immunol] 2022 Jun 09; Vol. 13, pp. 918565. Date of Electronic Publication: 2022 Jun 09 (Print Publication: 2022).
Zobrazit plný text záznamu
3
Akademický článek
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).
Autor: Soria-Juan B; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Garcia-Arranz M; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Llanos Jiménez L; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain. lucia.llanos@quironsalud.es., Aparicio C; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Gonzalez A; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Mahillo Fernandez I; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Riera Del Moral L; La Paz University Hospital, Madrid, Spain., Grochowicz L; Navarra University Clinic, Pamplona, Navarra, Spain., Andreu EJ; Navarra University Clinic, Pamplona, Navarra, Spain., Marin P; Virgen de la Arrixaca University Hospital, Murcia, Spain., Castellanos G; Virgen de la Arrixaca University Hospital, Murcia, Spain., Moraleda JM; Virgen de la Arrixaca University Hospital, Murcia, Spain., García-Hernández AM; Virgen de la Arrixaca University Hospital, Murcia, Spain., Lozano FS; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain., Sanchez-Guijo F; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain., Villarón EM; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain., Parra ML; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain., Yañez RM; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain., de la Cuesta Diaz A; Queen Victoria Eugenia-Cruz Roja Hospital, Sevilla, Spain., Tejedo JR; University of Pablo de Olavide, Sevilla, Spain., Bedoya FJ; University of Pablo de Olavide, Sevilla, Spain.; Network Center for Research in Diabetes and Associated Metabolic Diseases (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas-CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Martin F; University of Pablo de Olavide, Sevilla, Spain., Miralles M; La Fe University Hospital, Valencia, Spain., Del Rio Sola L; Valladolid Clinical University Hospital, Valladolid, Spain., Fernández-Santos ME; Institute for Health Research Gregorio Marañón (IISGM), General University Gregorio Marañón Hospital, Madrid, Spain., Ligero JM; Institute for Health Research Gregorio Marañón (IISGM), General University Gregorio Marañón Hospital, Madrid, Spain., Morant F; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain., Hernández-Blasco L; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain., Andreu E; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain.; University Miguel Hernández de Elche, Alicante, Spain., Hmadcha A; University of Pablo de Olavide, Sevilla, Spain.; The Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain.; University of Alicante, Alicante, Spain., Garcia-Olmo D; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Soria B; University of Pablo de Olavide, Sevilla, Spain.; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain.; University Miguel Hernández de Elche, Alicante, Spain.
Publikováno v: Trials [Trials] 2021 Sep 06; Vol. 22 (1), pp. 595. Date of Electronic Publication: 2021 Sep 06.
Zobrazit plný text záznamu
4
Akademický článek
Genetic Risk, Inflammation, and Therapeutics: An Editorial Overview of Recent Advances in Aging Brains and Neurodegeneration.
Autor: Gupta, Vivek1 vivek.gupta@mq.edu.au, Chitranshi, Nitin1, Gupta, Veer Bala2
Publikováno v: Aging & Disease. Oct2024, Vol. 15 Issue 5, p1989-1993. 5p.
Zobrazit plný text záznamu
5
Akademický článek
Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis.
Autor: Lamo-Espinosa JM; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain. jlamodeespi@unav.es.; Cell Therapy Area, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain. jlamodeespi@unav.es., Blanco JF; Department of Orthopaedic Surgery and Traumatology, Complejo Universitario de Salamanca-IBSAL, Salamanca, Spain., Sánchez M; Arthroscopic Surgery Unit, Hospital Vithas San José, Vitoria-Gasteiz, Spain.; Advanced Biological Therapy Unit, Hospital Vithas San José, Vitoria-Gasteiz, Spain., Moreno V; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain., Granero-Moltó F; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain.; Cell Therapy Area, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain., Sánchez-Guijo F; Department of Haematology, Complejo Hospitalario de Salamanca-IBSAL, Salamanca, Spain., Crespo-Cullel Í; Department of Orthopaedic Surgery and Traumatology, Complejo Universitario de Salamanca-IBSAL, Salamanca, Spain., Mora G; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain., San Vicente DD; Advanced Biological Therapy Unit, Hospital Vithas San José, Vitoria-Gasteiz, Spain., Pompei-Fernández O; Advanced Biological Therapy Unit, Hospital Vithas San José, Vitoria-Gasteiz, Spain., Aquerreta JD; Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain., Núñez-Córdoba JM; Division of Biostatistics, Research Support Service, Central Clinical Trials Unit, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Preventive Medicine and Public Health, Medical School, University of Navarra, Pamplona, Spain., Vitoria Sola M; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain., Valentí-Azcárate A; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain., Andreu EJ; Cell Therapy Area, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain., Del Consuelo Del Cañizo M; Department of Haematology, Complejo Hospitalario de Salamanca-IBSAL, Salamanca, Spain., Valentí-Nin JR; Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain., Prósper F; Cell Therapy Area, Clínica Universidad de Navarra, 36 Pío XII Avenue, 31008, Pamplona, Spain. fprosper@unav.es.; Department of Haematology, Clínica Universidad de Navarra, Pamplona, Spain. fprosper@unav.es.
Publikováno v: Journal of translational medicine [J Transl Med] 2020 Sep 18; Vol. 18 (1), pp. 356. Date of Electronic Publication: 2020 Sep 18.
Zobrazit plný text záznamu
6
Akademický článek
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.
Autor: Sánchez-Guijo F; Cell Therapy Area, Hematology Department, IBSAL-Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.; Grupo Español de Trasplante y Terapia Celular (GETH), Spain., García-Arranz M; RETIC TerCel, ISCIII, Madrid, Spain.; New Therapies Unit, Health Research Institute Fundación Jiménez Díaz, Madrid, Spain.; Surgery Department. School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., López-Parra M; Cell Therapy Area, Hematology Department, IBSAL-Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.; Grupo Español de Trasplante y Terapia Celular (GETH), Spain., Monedero P; Department of Anesthesia and Intensive Care, Clínica Universidad de Navarra, Pamplona, Spain., Mata-Martínez C; Instituto de Investigación Sanitaria (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain., Santos A; Intensive Care Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; CIBER de Enfermedades Respiratorias CIBERES, Madrid, Spain., Sagredo V; Intensive Care Unit, IBSAL- Hospital Universitario de Salamanca, University of Salamanca, Salamanca, Spain., Álvarez-Avello JM; Department of Anesthesia and Intensive Care, Clínica Universidad de Navarra, Pamplona, Spain., Guerrero JE; Instituto de Investigación Sanitaria (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain., Pérez-Calvo C; Intensive Care Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Sánchez-Hernández MV; Department of Anesthesia, IBSAL- Hospital Universitario de Salamanca, University of Salamanca, Salamanca, Spain., Del-Pozo JL; Infectious Diseases Division, Microbiology Department, Clínica Universidad de Navarra, Spain., Andreu EJ; RETIC TerCel, ISCIII, Madrid, Spain.; Cell Therapy Area and Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain., Fernández-Santos ME; RETIC TerCel, ISCIII, Madrid, Spain.; Instituto de Investigación Sanitaria (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain.; CIBER Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Soria-Juan B; New Therapies Unit, Health Research Institute Fundación Jiménez Díaz, Madrid, Spain., Hernández-Blasco LM; Hospital General Universitario de Alicante (Universidad Miguel Hernandez-ISABIAL), Alicante, Spain., Andreu E; Hospital General Universitario de Alicante (Universidad Miguel Hernandez-ISABIAL), Alicante, Spain., Sempere JM; Hospital General Universitario de Alicante (Departamento de Biotecnología, Universidad de Alicante-ISABIAL), Alicante, Spain., Zapata AG; RETIC TerCel, ISCIII, Madrid, Spain.; Department of Cell Biology, Universidad Complutense, Madrid, Spain., Moraleda JM; RETIC TerCel, ISCIII, Madrid, Spain.; Grupo Español de Trasplante y Terapia Celular (GETH), Spain.; Servicio de Hematología, Hospital Clinico Universitario Virgen de la Arrixaca, IMIB, Universidad de Murcia, Murcia, Spain., Soria B; Hospital General Universitario de Alicante (Universidad Miguel Hernandez-ISABIAL), Alicante, Spain.; Institute of Bioengineering, Universidad Miguel Hernández, Alicante, Spain., Fernández-Avilés F; RETIC TerCel, ISCIII, Madrid, Spain.; Instituto de Investigación Sanitaria (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain.; CIBER Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.; Department of Medicine, Universidad Complutense, Madrid, Spain., García-Olmo D; RETIC TerCel, ISCIII, Madrid, Spain.; New Therapies Unit, Health Research Institute Fundación Jiménez Díaz, Madrid, Spain.; Surgery Department. School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Department of Surgery, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Prósper F; RETIC TerCel, ISCIII, Madrid, Spain.; Grupo Español de Trasplante y Terapia Celular (GETH), Spain.; Cell Therapy Area and Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.
Publikováno v: EClinicalMedicine [EClinicalMedicine] 2020 Aug; Vol. 25, pp. 100454. Date of Electronic Publication: 2020 Jul 10.
Zobrazit plný text záznamu
7
Akademický článek
Combined PI3K/Akt and Smad2 Activation Promotes Corneal Endothelial Cell Proliferation.
Autor: Sabater AL; Area of Cell Therapy, Clínica Universidad de Navarra, Pamplona, Navarra, Spain 2Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain 3Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States., Andreu EJ; Area of Cell Therapy, Clínica Universidad de Navarra, Pamplona, Navarra, Spain., García-Guzmán M; Area of Cell Therapy, Clínica Universidad de Navarra, Pamplona, Navarra, Spain., López T; Area of Cell Therapy, Clínica Universidad de Navarra, Pamplona, Navarra, Spain., Abizanda G; Area of Cell Therapy, Clínica Universidad de Navarra, Pamplona, Navarra, Spain., Perez VL; Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States., Moreno-Montañés J; Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain., Prósper F; Area of Cell Therapy, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
Publikováno v: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2017 Feb 01; Vol. 58 (2), pp. 745-754.
Zobrazit plný text záznamu
8
Akademický článek
Prognostic value of PRR11 and immune cell infiltration in Ewing sarcoma.
Autor: Wen, Jian1,2 (AUTHOR), Wan, Lijia3 (AUTHOR), Dong, Xieping2 (AUTHOR) jxsrmyydongxieping@163.com
Publikováno v: PLoS ONE. 3/1/2024, Vol. 19 Issue 2, p1-21. 21p.
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje